This phase II trial tests how well enfortumab vedotin (EV) and pembrolizumab works in treating patients with bladder cancer of variant histology (a group of le…

Bladder Squamous Cell CarcinomaLocally Advanced Bladder CarcinomaMalignant Renal Pelvis Neoplasm+8 more

~Estimated

~$10 – $6,250

Emory UniversityNCT05756569

Management of Cisplatin-Ineligible Patients With Metastatic Bladder Cancer and The Role of Geriatric Assessments

The goal of this study is to better understand how to best treat participants with advanced bladder cancer who may not be able to tolerate all of the chemother…

Bladder CancerMetastatic Bladder CancerUnresectable Bladder Carcinoma+1 more

~Estimated

~$10 – $1,125

Dana-Farber Cancer InstituteNCT06138561